SEC Form 4 · accession 0000908662-15-000083
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Golumbeski
Director
Period of report
Feb 19, 2015
Accepted (ET)
Feb 20, 2015 · 4:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to bury)F1 | $33.65 | Feb 19, 2015 | A | 6,000 | A | — | Feb 19, 2025 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 19, 2015), with the final monthly installment vesting at the 2016 annual meeting of stockholders.